Sussex Biologicals introduces FIAPro Immunofluorescence Analyser
It is a multi-test point-of-care platform for rapid diagnostics in infection, cardiovascular, diabetes, and more.
See the latest news and media coverage for Sussex Biologicals. We track all announcements, press releases, and industry mentions in real time, all in one place.
Diagnostic reagents and testing systems manufacturer
sussexbiologicals.comLast updated
In short: Sussex Biologicals launched the FIAPro diagnostic platform and secured an NHS Blood and Transplant tender for red cell genotyping technology.
It is a multi-test point-of-care platform for rapid diagnostics in infection, cardiovascular, diabetes, and more.
It occurs on 21st April with inno-train Diagnostik from 12.30pm to 3pm, including lunch and refreshments. Registration remains open.
They exhibit with inno-train Diagnostik at Stand 5 and host an HLA NGS workshop on Tuesday 21st at Leonardo Hotel Haymarket.
They will supply Fluoqube for red cell genotyping across RCIs and SNBTS. This recognizes their technology and expertise in improving donor-patient matching.
A licensing structure assigns SteinCares end-to-end Latin America market execution while Shilpa retains development and sustained commercial supply responsibilities. The collaboration targets wider uptake of...
Allergy Therapeutics PLC shares declined on Monday, despite the firm saying it expects to report increased revenue for its first half.
A Southern Water bio-bead pollution incident in Sussex has been upgraded to the "most serious" category by the Environment Agency.
Track Sussex Biologicals and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Sussex Biologicals and other trending companies.